Tennessee approves bill targeting pharmacy benefit managers, raising hopes for relief on prescription prices

Tennessee lawmakers approve major pharmacy bill

Tennessee House lawmakers approved legislation that could reshape prescription medicine management, marking a significant policy shift aimed at addressing growing concerns over healthcare costs and system transparency statewide.

The move reflects rising pressure from policymakers and healthcare advocates who believe current structures contribute to high medication prices, encouraging efforts to improve accountability and fairness across prescription medicine systems.

Focus turns to pharmacy benefit managers

The legislation centers on pharmacy benefit managers, known as PBMs, which play a crucial role in negotiating medicine prices and managing prescription benefits for insurance providers nationwide.

These organizations decide which treatments to cover and set pricing structures, placing themselves at the center of ongoing debates about transparency, competition, and overall affordability within the healthcare system.

Understanding the role of PBMs in pricing

Pharmacy benefit managers serve as intermediaries among medicine manufacturers, insurers, and pharmacies, negotiating discounts and establishing formularies that determine how patients access medications across insurance plans.

Their decisions directly affect patients’ out-of-pocket costs and pharmacy reimbursement rates, making them highly influential in shaping prescription medicine pricing across the broader healthcare system.

New restrictions on ownership structures

The proposed law would require an entity to divest if it owns or controls a pharmacy while also owning or controlling both a pharmacy benefit manager and a health insurance issuer operating in Tennessee.

This requirement prevents companies from controlling multiple parts of the prescription medicine system at once, reducing the risk that a single organization can influence pricing, coverage decisions, and pharmacy operations simultaneously.

Bill introduction sparks immediate reactions

Introduced in January, the bill quickly drew attention from major healthcare companies and industry stakeholders, triggering widespread discussion about its potential impact on pharmacy operations and patient access.

As the proposal gained momentum, companies and advocacy groups began evaluating how these regulatory changes might affect business models, healthcare delivery, and long-term cost structures across the system.

CVS warns of potential pharmacy closures

CVS Health responded by warning that more than 130 pharmacies could close if the legislation is enacted, raising concerns about reduced access to essential pharmacy services for communities.

The company argued that such closures would result from operational disruptions caused by new restrictions, potentially affecting patients who rely on local pharmacies for prescriptions and routine healthcare services.

Fun fact: CVS began as Consumer Value Store in Lowell in 1963, selling health and beauty products before pharmacies expanded across America.

Advertising campaign escalates the debate

By late March, CVS Health had spent about $1.3 million on television advertising campaigns aimed at opposing the legislation and shaping public opinion around its potential consequences.

This outreach effort demonstrated the intensity of the debate, as corporate stakeholders sought to directly influence voters and policymakers through messaging that highlighted concerns about access, costs, and healthcare stability.

Little-known fact: CVS Health operates about 9,000 stores nationwide, giving it one of the largest retail healthcare footprints in the United States today.

Attorney general addresses communication concerns

Tennessee Attorney General Jonathan Skrmetti sent a letter to CVS Health leadership addressing concerns about how the company communicated with consumers regarding the proposed legislation.

The letter warned against using phone numbers collected for pharmacy alerts to send policy-related messages, raising questions about data usage practices and the boundaries of consumer communication in healthcare contexts.

Supporters emphasize benefits for local pharmacies

Supporters argue the bill would strengthen independent pharmacies by creating fairer competition, allowing smaller providers to operate without facing disadvantages tied to vertically integrated corporate structures.

They also stress that the legislation does not require closures, instead focusing on balancing the market so local pharmacies can continue serving communities without being overshadowed by larger healthcare entities.

Critics question impact on affordability

Opponents, including CVS Health, argue the bill does not directly address affordability issues such as reimbursement models, pricing transparency, or formulary restrictions affecting patients and providers.

They warn that the legislation could create unintended disruptions, potentially reducing access to care and complicating how patients receive medications through existing pharmacy networks and insurance arrangements.

Audit highlights spread pricing practices

A 2024 audit by Tennessee regulators found that CVS Caremark used spread pricing, charging health plans more for medications than pharmacies received for dispensing them.

This pricing model led some entities to pay more than the actual cost of medications, raising concerns about transparency and fairness in how prescription transactions are managed within the system.

Company warns of broader consequences

CVS Health stated the legislation could lead to closing 25 MinuteClinic locations and result in more than 2,000 job losses across Tennessee if implemented.

The company also signaled possible legal action, indicating it may challenge the law in federal court, suggesting the issue could evolve into a broader legal and regulatory dispute beyond state policymaking.

Want to read more about the latest news? Check out how the rising fuel costs have pushed Democrats to make the case for clean energy and lower household bills.

Bill advances to governor for final decision

After passing both legislative chambers, the bill now awaits review by Governor Bill Lee, who will determine whether it becomes law or faces further revisions.

This final decision could shape how prescription medicine systems operate in Tennessee and may influence similar policy discussions in other states considering reforms targeting pharmacy benefit managers.

Want to stay ahead of the news? Take a look at how the lawsuit from Vietnam veterans targets ‘Trump arch’ proposal at Arlington, amid ambitious changes in Washington.

What stands out more to you, Tennessee’s move to target pharmacy benefit managers, or the broader concerns about how drug pricing and healthcare costs are being managed? Share your thoughts.

This slideshow was made with AI assistance and human editing.

Read More From This Brand:

• Local schools face growing strain as delays in state budget decisions impact funding and daily operations
• Concern rises among Iowa farmers as Trump economy pressures leave them on the edge of something bad
• Anti-fraud legislation in Minnesota runs into trouble amid funding dispute over the Attorney General’s office